Addressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment options
about
Treating Negative Symptoms in Schizophrenia: an UpdateSignificant weight loss following clozapine use, how is it possible? A case report and review of published cases and literature relevant to the subjectPerspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end?Motive-oriented therapeutic relationship building for patients diagnosed with schizophrenia.Prenatal Nicotine Exposure Impairs the Proliferation of Neuronal Progenitors, Leading to Fewer Glutamatergic Neurons in the Medial Prefrontal Cortex.Converging effects of diverse treatment modalities on frontal cortex in schizophrenia: A review of longitudinal functional magnetic resonance imaging studies.Effects of second-generation antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome components in first-episode schizophrenia patients.Altered neuronal excitability underlies impaired hippocampal function in an animal model of psychosis.Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms.Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in JapanSex differences in GABAergic gene expression occur in the anterior cingulate cortex in schizophrenia.Epidemiology and Treatment Guidelines of Negative Symptoms in Schizo-phrenia in Central and Eastern Europe: A Literature Review.The National Institute of Mental Health Research Domain Criteria and Clinical Research in Child and Adolescent PsychiatryEmerging drugs for schizophrenia: an update.Fatty acid and vitamin interventions in adults with schizophrenia: a systematic review of the current evidence.Quality-adjusted life year difference in patients with predominant negative symptoms of schizophrenia treated with cariprazine and risperidone.Burden of illness of people with persistent symptoms of schizophrenia: A multinational cross-sectional study.Motivational assessment of mice using the touchscreen operant testing system: effects of dopaminergic drugs.Negative symptoms in first-episode psychosis: Clinical correlates and 1-year follow-up outcomes in London Early Intervention Services.Are negative symptoms in schizophrenia a distinct therapeutic target?Benzoate and Sorbate Salts: A Systematic Review of the Potential Hazards of These Invaluable Preservatives and the Expanding Spectrum of Clinical Uses for Sodium Benzoate
P2860
Q26744805-D3D82D41-E59E-49F9-8737-6C7FCF5457AFQ28073082-886AA88B-D2A3-49F1-9731-B6B01FB82481Q30379983-5671F813-84BD-4AA2-A414-EBC6BDE6AB65Q30402711-2D9C3C84-6834-4C7E-A1DD-DB5C3DA10F7BQ30830261-B3031D16-8522-41FA-BF28-15978113275AQ31138746-46FD38F8-82CB-4551-B337-F3A7EEBB3D66Q34484974-EC160341-92D3-4488-BDB0-120B44E003BEQ35626044-BFF871F8-7391-4ADE-AC04-5A3F59056E24Q35798084-BBCFB528-9080-4D0E-A746-E20F9600D3BBQ35850831-8A95DA28-8F0E-4CD7-B8FF-81DBC3C3B0DEQ35915861-010B399A-B4C1-4DEE-94E6-73BEB3F0E00FQ36232324-03B5F818-23C9-4BF6-8E5B-B3BA54DF5E7AQ36494454-AC2B3945-D25C-4335-9CDB-FDC0AE1C5412Q38252404-8B8F0878-5817-4CFC-A90F-B6C53205AE8DQ38583706-754DC595-FCCD-4B8C-B74F-915E0FC10BFAQ38782286-A820F952-7260-4135-9614-F59772C1E788Q38992595-A5AFC68C-0C63-4F2A-9819-5404189A927EQ41779069-A1EAA6A6-1612-44F3-8350-1DD813C09E80Q47573483-99465D8E-A77A-4EF2-8CD7-AAF02608D9B7Q49381903-5D530D3B-D5E8-4AAC-BD8C-51124AE41C1BQ56481952-748A10AB-9E55-4ADA-9121-5B7A6AE977A2
P2860
Addressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment options
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Addressing the unmet needs of ...... rmacological treatment options
@ast
Addressing the unmet needs of ...... rmacological treatment options
@en
Addressing the unmet needs of ...... rmacological treatment options
@en-gb
Addressing the unmet needs of ...... rmacological treatment options
@nl
type
label
Addressing the unmet needs of ...... rmacological treatment options
@ast
Addressing the unmet needs of ...... rmacological treatment options
@en
Addressing the unmet needs of ...... rmacological treatment options
@en-gb
Addressing the unmet needs of ...... rmacological treatment options
@nl
prefLabel
Addressing the unmet needs of ...... rmacological treatment options
@ast
Addressing the unmet needs of ...... rmacological treatment options
@en
Addressing the unmet needs of ...... rmacological treatment options
@en-gb
Addressing the unmet needs of ...... rmacological treatment options
@nl
P2860
P921
P3181
P356
P1476
Addressing the unmet needs of ...... rmacological treatment options
@en
P2093
Justine Lalonde
Pierre Chue
P2860
P3181
P356
10.2147/NDT.S43404
P407
P577
2014-05-01T00:00:00Z